Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 3 studies | 19% ± 3% |
Insufficient scRNA-seq data for expression of WDR81 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 3689.10 | 1809 / 1809 | 100% | 45.44 | 470 / 472 |
esophagus | 100% | 2291.67 | 1439 / 1445 | 99% | 22.08 | 182 / 183 |
kidney | 100% | 2077.49 | 89 / 89 | 98% | 22.90 | 884 / 901 |
thymus | 100% | 2745.59 | 653 / 653 | 98% | 14.48 | 593 / 605 |
prostate | 100% | 3554.03 | 245 / 245 | 98% | 15.20 | 490 / 502 |
breast | 100% | 3896.32 | 459 / 459 | 97% | 15.35 | 1089 / 1118 |
intestine | 100% | 3006.07 | 966 / 966 | 97% | 13.20 | 513 / 527 |
uterus | 100% | 4331.75 | 170 / 170 | 97% | 12.57 | 444 / 459 |
bladder | 100% | 3450.71 | 21 / 21 | 97% | 13.85 | 487 / 504 |
liver | 100% | 2928.33 | 226 / 226 | 97% | 14.85 | 392 / 406 |
lung | 99% | 3473.58 | 573 / 578 | 97% | 16.68 | 1125 / 1155 |
stomach | 99% | 1999.38 | 357 / 359 | 97% | 15.20 | 276 / 286 |
pancreas | 97% | 1407.53 | 318 / 328 | 98% | 15.88 | 174 / 178 |
brain | 94% | 1121.79 | 2489 / 2642 | 99% | 19.52 | 699 / 705 |
ovary | 100% | 4437.27 | 180 / 180 | 87% | 11.45 | 373 / 430 |
adrenal gland | 100% | 3341.72 | 258 / 258 | 82% | 8.97 | 188 / 230 |
adipose | 100% | 3713.34 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 64.95 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 31.28 | 29 / 29 |
spleen | 100% | 5271.34 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 20.39 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.83 | 1 / 1 |
muscle | 100% | 2374.31 | 801 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 2162.51 | 1323 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 1331.04 | 823 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 1595.99 | 882 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0007005 | Biological process | mitochondrion organization |
GO_0045022 | Biological process | early endosome to late endosome transport |
GO_0035973 | Biological process | aggrephagy |
GO_0050821 | Biological process | protein stabilization |
GO_0010008 | Cellular component | endosome membrane |
GO_0031901 | Cellular component | early endosome membrane |
GO_0000421 | Cellular component | autophagosome membrane |
GO_0031902 | Cellular component | late endosome membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0035014 | Molecular function | phosphatidylinositol 3-kinase regulator activity |
GO_0141039 | Molecular function | phosphatidylinositol 3-kinase inhibitor activity |
GO_0070530 | Molecular function | K63-linked polyubiquitin modification-dependent protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | WDR81 |
Protein name | WD repeat domain 81 (WD repeat-containing protein 81) WDR81 protein WD repeat-containing protein 81 |
Synonyms | |
Description | FUNCTION: Functions as a negative regulator of the PI3 kinase/PI3K activity associated with endosomal membranes via BECN1, a core subunit of the PI3K complex. By modifying the phosphatidylinositol 3-phosphate/PtdInsP3 content of endosomal membranes may regulate endosome fusion, recycling, sorting and early to late endosome transport . It is for instance, required for the delivery of cargos like BST2/tetherin from early to late endosome and thereby participates indirectly to their degradation by the lysosome . May also play a role in aggrephagy, the macroautophagic degradation of ubiquitinated protein aggregates. In this process, may regulate the interaction of SQSTM1 with ubiquitinated proteins and also recruit MAP1LC3C . May also be involved in maintenance of normal mitochondrial structure and organization (By similarity). . |
Accessions | ENST00000631907.1 ENST00000631560.1 ENST00000419248.5 [Q562E7-6] ENST00000575206.1 ENST00000615141.4 A0A0J9YXM6 I3L1G2 ENST00000613381.4 [Q562E7-6] ENST00000468539.5 ENST00000455636.5 Q562E7 ENST00000613616.3 [Q562E7-5] C9JCF9 ENST00000611758.2 [Q562E7-3] ENST00000309182.9 [Q562E7-3] ENST00000437219.6 [Q562E7-5] Q24JR4 ENST00000634001.1 ENST00000446363.5 ENST00000632244.1 ENST00000418841.5 ENST00000632313.1 ENST00000474958.2 ENST00000632643.1 I3L3U7 E9PDG3 C9JD20 K7ELV8 ENST00000409644.6 [Q562E7-1] |